Preclinical and clinical studies of bone marrow uptake of fluorine-18- fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy

Journal of Clinical Oncology

Volumn 16, Issue 1, 1998, Pages 173-180

  Sugawara, Yoshifumi ^a   Fisher, Susan J ^a   Zasadny, Kenneth R ^a   Kison, Paul V ^a   Baker, Laurence H ^a   Wahl, Richard L ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONJUGATED ESTROGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; METHOTREXATE; TAMOXIFEN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; BONE MARROW METASTASIS; BONE MARROW SCINTISCANNING; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; CLINICAL PRACTICE; CONTROLLED STUDY; DRUG DISTRIBUTION; FEMALE; GLUCOSE METABOLISM; HUMAN; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; LEUKOCYTE COUNT; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0031972860     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1998.16.1.173     Document Type: Article

References (38)

1. Groopman JE, Molina J-M, Scadden DT: Hematopoietic growth factors: Biology and clinical applications. N Engl J Med 321:1449-1459, 1989
2. Peters WP: The effect of recombinant human colony-stimulating factors on hematopoietic reconstitution following autologous bone marrow transplantation. Semin Hematol 26:18-23, 1989 (suppl 2)
3. Weisbart RH, Golde DW: Physiology of granulocyte and macrophage colony-stimulating factors in host defense. Hematol Oncol Clin North Am 3:401-409, 1989
4. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:28-35, 1992
5. Lieschke GJ, Burgess AW: Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. N Engl J Med 327:99-106, 1992
6. Crawford J, Ozer H, Stoller R, et al: Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med 325:164-170, 1991
7. Reske SN: Recent advances in bone marrow scanning. Eur J Nucl Med 18:203-221, 1991
8. Shpall EJ, Gee AP, Hogan C, et al: Bone marrow metastases. Hematol Oncol Clin North Am 10:321-343, 1996
9. Vogler JB III, Murphy WA: Bone marrow imaging. Radiology 168:679-693, 1988
10. Petren-Mallmin M: Clinical and experimental imaging of breast cancer metastases in the spine. Acta Radiol 391:1-23. 1994 (suppl)
11. Podoloff DA, Kim EE: "Sub"-super scan-manifestation of bone marrow metastases? Clin Nucl Med 14:597-602, 1989
12. Rieker O, Grunwald F, Layer G. et al: Dissemination bone marrow metastases from primary breast cancer: Detection and follow-up by radioimmune bone marrow scintigraphy. J Nucl Med 35:1485-1487, 1994
13. Schneider JA, Divgi CR, Scott AM, et al: Flare on bone scintigraphy following Taxol chemotherapy for metastatic breast cancer. J Nucl Med 35:1748-1752, 1994
14. Abdel-Dayem HM, Sanchez J, Al-Mohannadi S, et al: Diffuse thallium-201-chloride uptake in hypermetabolic bone marrow following treatment with granulocyte stimulating factor. J Nucl Med 33:2014-2016, 1992
15. 99mTc-sulphur colloid during granulocyte colony-stimulating factor administration in autologous bone marrow transplantation. Nucl Med Commun 14:896-901, 1993
16. Stokkel MP, Valdes Olmos RA, Hoefnagel CA, et al: Tumor and therapy associated abnormal changes on bone scintigraphy. Old and new phenomena. Clin Nucl Med 18:821-828, 1993
17. Valdes Olmos RA, Hoefnagel CA, van der School JB: Nuclear medicine in the monitoring of organ function and the detection of injury related to cancer therapy. Eur J Nucl Med 20:515-546, 1993
18. Fletcher BD. Wall JE, Hanna SL: Effect of hematopoietic growth factors on MR images of bone marrow in children undergoing chemotherapy. Radiology 189:745-751, 1993
19. Strauss LG, Clonus JH, Schlag P, et al: Recurrence of colorectal tumors: PET evaluation. Radiology 170:329-332, 1989
20. Strauss LG, Conti PS: The applications of PET in clinical oncology. J Nucl Med 32:623-648, 1991
21. Wahl RL, Zasadny K, Helvie M, et al: Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: Initial evaluation. J Clin Oncol 11:2101-2111, 1993
22. Wahl RL, Hutchins GD, Buchsbaum DJ, et al: 18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts: Feasibility studies for cancer imaging with positron-emission tomography. Cancer 67:1544-1550, 1991
23. Wahl RL, Cody RL, Hutchins GD, et al: Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabeled glucose analogue 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology 179:765-770, 1991
24. Newman JS, Francis IR, Kaminski MS, et al: Imaging of lymphoma with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose: correlation with CT. Radiology 190:111-116, 1994
25. Wahl RL, Quint LE, Greenough RL, et al: Staging of mediastinal non-small cell lung cancer with FDG PET, CT, and fusion images: Preliminary prospective evaluation. Radiology 191:371-377, 1994
26. Som P, Atkins HL, Bandoypadhyay D, et al: A fluorinated glucose analog. 2-fluoro-2-deoxy-D-glucose (F-18): Nontoxic tracer for rapid tumor detection. J Nucl Med 21:670-675, 1980
27. 18F]fluoro-D-glucose (FDG) for the detection of tumor involvement in lymph nodes. J Nucl Med 31:1831-1835, 1990
28. Harney JV, Wahl RL, Liebert M, et al: Uptake of 2-deoxy, 2-(18F) fluoro-D-glucose in bladder cancer: Animal localization and initial patient positron emission tomography. J Urol 145:279-283, 1991
29. Wahl RL, Henry CA, Ethier SP: Serum glucose: Effect on tumor and normal tissue accumulation of 2-[F-18]-fluoro-2-deoxy-D-glucose in rodents with mammary carcinoma. Radiology 183:643-647, 1992
30. Yao W-J, Hoh CK, Hawkins RA, et al: Quantitative PET imaging of bone marrow glucose metabolic response to hematopoietic cytokines. J Nucl Med 36:794-799, 1995
31. Minn H, Zasadny KR, Quint LE, et al: Lung cancer: Reproducibility of quantitative measurements for evaluating 2-[F-18]-fluoro-2-deoxy-D-glucose uptake at PET. Radiology 196:167-173, 1995
32. Zasadny KR, Wahl RL: Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction. Radiology 189:847-850, 1993
33. Hamilton JA, Vario G, Lingelbach SR: CSF-1 stimulates glucose uptake in murine bone marrow-derived macrophages. Biochem Biophys Res Commun 138:445-454, 1986
34. Hamilton JA, Vairo G, Lingelbach SR: Activation and proliferation signals in murine macrophages: Stimulation of glucose uptake by hemopoietic growth factors and other agents. J Cell Physiol 134:405-412, 1988
35. Lang AH, Bagby GJ, Dobrescu C, et al: Modulation of glucose metabolic response to endotoxin by granulocyte colony-stimulating factor. Am J Physiol 263:R1122-1129, 1992
36. Ryder JW, Lazarus HM, Farhi DC: Bone marrow and blood findings after marrow transplantation and rhGM-CSF therapy. Am J Clin Pathol 97:631-637, 1992
37. Schmitz LL, McClure JS, Litz CE, et al: Morphologic and quantitative changes in blood and marrow cells following growth factor therapy. Am J Clin Pathol 101:67-75, 1994
38. Pekarske S, Shin SS: Bone marrow changes induced by recombinant granulocyte colony-stimulating factor resembling metastatic carcinoma: Distinction with cytochemical and immunohistochemical studies. Am J Hematol 51:332-334, 1996 (letter)